Short-Term Outcomes and Predictors of Effectiveness of Tocilizumab in Systemic Juvenile Idiopathic Arthritis: A Prospective Cohort Study

Background: Systemic Juvenile Idiopathic Arthritis (sJIA) is a unique category of juvenile arthritis in which interleukin 6 plays a major pathogenic role. This study aimed to describe the therapeutic short-term outcomes among patients with sJIA starting tocilizumab (TCZ) therapy and to identify poss...

Descripción completa

Detalles Bibliográficos
Autores principales: Nada, Doaa W., Moghazy, Abdelkawy, Allam, Abdallah El-Sayed, Alunno, Alessia, Ibrahim, Amira M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141590/
https://www.ncbi.nlm.nih.gov/pubmed/34041254
http://dx.doi.org/10.3389/fmed.2021.665028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141590/
https://www.ncbi.nlm.nih.gov/pubmed/34041254
http://dx.doi.org/10.3389/fmed.2021.665028

Ejemplares similares